Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Viemed Healthcare Inc VMD

Viemed Healthcare, Inc. through its subsidiaries, is a provider of home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The Company’s service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counselling to patients in their homes using cutting edge technologies. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, and other medical equipment. In-home sleep testing provides in home sleep apnea testing services. Healthcare staffing provides healthcare staffing and recruitment services. The Company provides home medical equipment services through its interest in East Alabama HomeMed, LLC (HomeMed).


NDAQ:VMD - Post by User

Comment by lscfaon May 29, 2021 3:06pm
315 Views
Post# 33292865

RE:RE:RE:RE:RE:RE:Bad news/ Good news

RE:RE:RE:RE:RE:RE:Bad news/ Good news

Phantom plan is getting smaller. Mgmt knows shareholders hate it.
 

 

Phantom sh plan

 

 

 

 

 

No of Shs o/s

Issued

Vested 

Expired

Jun30/21 (e)

571,000

350,000

700,000

30,000

Mar31/21

951,000

0

0

34,000

Dec31/20

985,000

0

0

34,000

Sep30/20

1,019,000

0

0

23,000

Jun30/20

1,042,000

346,000

601,000

31,000

Mar31/20

1,328,000

0

0

22,000

Dec31/19

1,350,000

0

0

33,000

Sep30/19

1,383,000

0

0

38,000

Jun30/19

1,421,000

351,000

550,000

17,000

Mar31/19

1,637,000

0

0

55,000

Dec31/18

1,692,000

0

0

29,000

Sep30/18

1,721,000

0

0

36,000

Jun30/18

1,757,000

1,793,000

0

36,000

Mar31/18

0

0

0

0

Dec31/17

0

 

 

 

 



HatrikSeLaine wrote: It's true that they have to follow a mark-to-market approach and that they must record a fair market value expense each quarter based on formulas under standard GAAP (FAS accounting rules).  And yes it can cause a lot of noise when the stock is volatile.  When times are good, and share price is climbing you have to up your current quarterly expense causing a bit of a head wind.  When times are bad, and so is declining, you get the bonus at least of reducing stock based comp expenses to help EPS.  This is the nature of Long Term Incentives and applies to any Plan offering; stock option grants, restricted share units, restricted stock units, phantom shares etc.   It's the name of the game and all publically traded companies offering these incentives to retain and attract top executives has to abide by these accounting rules.   Don't blame stock based comp. on the companies latest tumble in price.  These expenses are a drop in the bucket vs. Regulatory issues that keep popping up and frustrating us all.

 

<< Previous
Bullboard Posts
Next >>